Halometasone

卤米松

Report date: 2023/02/23 20:00:33
NME

Base Information

Drug NameHalometasone
Drug Alias Namehalometasonum卤甲松halometasona新适确得Sicorten +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsPsoriasisDermatitis
Global Approved IndicationsPsoriasisDermatitis
Approved Indications in ChinaPsoriasisDermatitis
Original Approved Country/TerritoryHong Kong
Original Approved DateN/A
Country/TerritoryHong KongMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBright Future Pharmaceuticals FactoryChongqing Huapont Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasisDermatitis
Inactive IndicationsN/A

Other Information

ATC CodeD07AC12
Related LinksWikipediaKEGG